Abstract: This invention is directed to phenylimidazole compounds, which are PDE10A enzyme inhibitors useful for the treatment of neurological and psychiatric disorders.
Type:
Grant
Filed:
June 19, 2009
Date of Patent:
March 13, 2012
Assignee:
H. Lundbeck A/S
Inventors:
Andreas Ritzén, Jan Kehler, Morten Langgård, Jacob Nielsen, John Paul Kilburn